Manufacturer
Sanofi-Aventis Deutschland GmbH
Contents
Buserelin acetate
Indication
Advanced prostatic carcinoma, Pituitary desensitisation before ovulation induction with gonadotrophins.
Instruction
Administer via Subcutaneous Injection.
Drug interaction
Drugs affecting pituitary secretion of gonadotrophins, hormonal therapy and corticosteroids may alter the response. Spironolactone and levodopa can stimulate secretion of gonadotrophins. Phenothiazines, dopamine antagonists, digoxin and sex hormones can inhibit gonadotrophin secretion.
Sanofi-Aventis Deutschland GmbH
Contents
Buserelin acetate
Indication
Advanced prostatic carcinoma, Pituitary desensitisation before ovulation induction with gonadotrophins.
Instruction
Administer via Subcutaneous Injection.
Drug interaction
Drugs affecting pituitary secretion of gonadotrophins, hormonal therapy and corticosteroids may alter the response. Spironolactone and levodopa can stimulate secretion of gonadotrophins. Phenothiazines, dopamine antagonists, digoxin and sex hormones can inhibit gonadotrophin secretion.
Inquiry - Suprefact Injection Solution